- Conditions
- Bioequivalence
- Interventions
- Pharmaceutical-lipid aspirin (PL-ASA)
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Lenexa, Kansas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- PL2200 Aspirin Capsules, Immediate-Release Aspirin Tablets, Enteric-coated aspirin caplets
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 21 Years to 79 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Upper Gastrointestinal Mucosal Damage
- Interventions
- acetylsalicylic acid
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 50 Years to 75 Years
- Enrollment
- 204 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 6
- States / cities
- Jupiter, Florida • South Miami, Florida • Oklahoma City, Oklahoma + 3 more
- Conditions
- Healthy Volunteers
- Interventions
- Naproxen, PL 3100
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Healthy
- Interventions
- PL2200 fasted, PL2200 fed
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2010
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Gastroduodenal Ulceration
- Interventions
- PL2200, Aspirin tablets
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 50 Years to 75 Years
- Enrollment
- 247 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 10
- States / cities
- Jupiter, Florida • South Miami, Florida • Towson, Maryland + 7 more
- Conditions
- Healthy Volunteers
- Interventions
- PL-ASA
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Gastroduodenal Ulcerations, Erosion
- Interventions
- PL3100, Naproxen
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 50 Years to 75 Years
- Enrollment
- 77 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010
- U.S. locations
- 2
- States / cities
- Dallas, Texas • Houston, Texas
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- PL2200 Aspirin Capsules, Enteric-coated aspirin caplets
- Drug
- Lead sponsor
- PLx Pharma
- Industry
- Eligibility
- 21 Years to 79 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 3
- States / cities
- Miami, Florida • Lenexa, Kansas • Cincinnati, Ohio